COMPLETED

Implantable Long-Acting Pre-Exposure Prophylaxis For MSM

Talk to us

Conditions

HIV PreventionPre Exposure ProphylaxisHIVMSMPrimary Care

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The long-term goal of this project is to better understand factors at the patient and physician level that can be addressed to impact uptake of long-acting, implantable PrEP (LA-PrEP) products in the future and identify the training needs of physicians. This project specifically focuses on men who have sex with men (MSM) seen in primary care settings in Texas. The main objective of this project is to examine perspectives of MSM and physicians in Texas regarding LA-PrEP, including attitudes and barriers to use and implementation by interviewing patients and physicians from the same clinical practices.

Official Title

Implantable Long-Acting Pre-Exposure Prophylaxis for HIV Prevention With MSM: A Qualitative Study of Patient and Physician Perspectives

Quick Facts

Study Start:2024-06-14
Study Completion:2025-09-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05420207

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 45 Years
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients must meet the following criteria:
  2. 1. be a patient of one of the practices where physicians have agreed to participate or have been seen for a primary care visit in the past 12 months in the Dallas Austin, or San Antonio metro areas;
  3. 2. be aged 18-45;
  4. 3. be assigned male sex at birth and report having one or more male sexual partners in the past year; and
  5. 4. be HIV negative.
  6. * Physicians who are interested in participating must be a practicing primary care physician in the Dallas, San Antonio, or Austin metropolitan area and be willing to allow recruitment of patient participants from their practice.
  1. * Those individuals who speak a language other than English or Spanish will be excluded as well as those who present with a cognitive or other impairment that would prevent them for consenting to participate in the study.

Contacts and Locations

Principal Investigator

Elizabeth Arnold, PhD
PRINCIPAL_INVESTIGATOR
University of Kentucky

Study Locations (Sites)

University of Pittsburgh
Pittsburgh, Pennsylvania, 15261
United States
Dell Medical School, UT-Austin
Austin, Texas, 78712
United States

Collaborators and Investigators

Sponsor: Elizabeth Arnold

  • Elizabeth Arnold, PhD, PRINCIPAL_INVESTIGATOR, University of Kentucky

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-06-14
Study Completion Date2025-09-05

Study Record Updates

Study Start Date2024-06-14
Study Completion Date2025-09-05

Terms related to this study

Keywords Provided by Researchers

  • Pre Exposure Prophylaxis
  • HIV
  • MSM
  • Primary Care

Additional Relevant MeSH Terms

  • HIV Prevention